Ad is loading...
ABCL
Price
$2.72
Change
-$0.00 (-0.00%)
Updated
Nov 21 closing price
95 days until earnings call
ONCY
Price
$0.98
Change
-$0.00 (-0.00%)
Updated
Nov 21 closing price
104 days until earnings call
Ad is loading...

ABCL vs ONCY

Header iconABCL vs ONCY Comparison
Open Charts ABCL vs ONCYBanner chart's image
AbCellera Biologics
Price$2.72
Change-$0.00 (-0.00%)
Volume$1.43M
CapitalizationN/A
Oncolytics Biotech
Price$0.98
Change-$0.00 (-0.00%)
Volume$289.76K
CapitalizationN/A
ABCL vs ONCY Comparison Chart
Loading...
ABCL
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
ONCY
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
ABCL vs. ONCY commentary
Nov 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABCL is a Hold and ONCY is a Sell.

COMPARISON
Comparison
Nov 23, 2024
Stock price -- (ABCL: $2.72 vs. ONCY: $0.98)
Brand notoriety: ABCL and ONCY are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ABCL: 68% vs. ONCY: 50%
Market capitalization -- ABCL: $803.4M vs. ONCY: $77.22M
ABCL [@Biotechnology] is valued at $803.4M. ONCY’s [@Biotechnology] market capitalization is $77.22M. The market cap for tickers in the [@Biotechnology] industry ranges from $463.61B to $0. The average market capitalization across the [@Biotechnology] industry is $2.63B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABCL’s FA Score shows that 0 FA rating(s) are green whileONCY’s FA Score has 0 green FA rating(s).

  • ABCL’s FA Score: 0 green, 5 red.
  • ONCY’s FA Score: 0 green, 5 red.
According to our system of comparison, ABCL is a better buy in the long-term than ONCY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABCL’s TA Score shows that 6 TA indicator(s) are bullish while ONCY’s TA Score has 4 bullish TA indicator(s).

  • ABCL’s TA Score: 6 bullish, 4 bearish.
  • ONCY’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, ABCL is a better buy in the short-term than ONCY.

Price Growth

ABCL (@Biotechnology) experienced а -1.45% price change this week, while ONCY (@Biotechnology) price change was -2.97% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.14%. For the same industry, the average monthly price growth was -4.97%, and the average quarterly price growth was +4.04%.

Reported Earning Dates

ABCL is expected to report earnings on Feb 25, 2025.

ONCY is expected to report earnings on Mar 06, 2025.

Industries' Descriptions

@Biotechnology (+2.14% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ABCL($815M) has a higher market cap than ONCY($73.3M). ONCY YTD gains are higher at: -27.407 vs. ABCL (-52.364). ONCY has higher annual earnings (EBITDA): -34.96M vs. ABCL (-202.4M). ABCL has more cash in the bank: 643M vs. ONCY (19.6M). ONCY has less debt than ABCL: ONCY (1.06M) vs ABCL (71.4M). ABCL has higher revenues than ONCY: ABCL (33M) vs ONCY (0).
ABCLONCYABCL / ONCY
Capitalization815M73.3M1,112%
EBITDA-202.4M-34.96M579%
Gain YTD-52.364-27.407191%
P/E RatioN/AN/A-
Revenue33M0-
Total Cash643M19.6M3,281%
Total Debt71.4M1.06M6,711%
FUNDAMENTALS RATINGS
ONCY: Fundamental Ratings
ONCY
OUTLOOK RATING
1..100
4
VALUATION
overvalued / fair valued / undervalued
1..100
71
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
64
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ABCLONCY
RSI
ODDS (%)
Bearish Trend 3 days ago
90%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
74%
Momentum
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
82%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
82%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
83%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
84%
Advances
ODDS (%)
Bullish Trend 26 days ago
75%
Bullish Trend 4 days ago
80%
Declines
ODDS (%)
Bearish Trend 8 days ago
86%
Bearish Trend 2 days ago
84%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
77%
Aroon
ODDS (%)
Bullish Trend 2 days ago
76%
Bearish Trend 2 days ago
83%
View a ticker or compare two or three
Ad is loading...
ABCL
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
ONCY
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ORGN1.190.16
+15.53%
Origin Materials
AZN64.261.06
+1.68%
AstraZeneca PLC
KAR19.840.18
+0.92%
OPENLANE
FCN198.18-0.80
-0.40%
FTI Consulting
OLMA7.87-0.41
-4.95%
Olema Pharmaceuticals

ABCL and

Correlation & Price change

A.I.dvisor indicates that over the last year, ABCL has been loosely correlated with VCYT. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if ABCL jumps, then VCYT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABCL
1D Price
Change %
ABCL100%
+1.87%
VCYT - ABCL
56%
Loosely correlated
-0.66%
PRME - ABCL
55%
Loosely correlated
-0.67%
BEAM - ABCL
54%
Loosely correlated
-3.72%
ADPT - ABCL
53%
Loosely correlated
-1.13%
DNA - ABCL
53%
Loosely correlated
+3.62%
More

ONCY and

Correlation & Price change

A.I.dvisor indicates that over the last year, ONCY has been loosely correlated with SRRK. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if ONCY jumps, then SRRK could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ONCY
1D Price
Change %
ONCY100%
-1.85%
SRRK - ONCY
38%
Loosely correlated
-4.27%
ABCL - ONCY
34%
Loosely correlated
+1.87%
RCUS - ONCY
27%
Poorly correlated
-2.33%
UBX - ONCY
27%
Poorly correlated
-0.85%
VCYT - ONCY
27%
Poorly correlated
-0.66%
More